199 related articles for article (PubMed ID: 21393506)
1. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
Civenni G; Walter A; Kobert N; Mihic-Probst D; Zipser M; Belloni B; Seifert B; Moch H; Dummer R; van den Broek M; Sommer L
Cancer Res; 2011 Apr; 71(8):3098-109. PubMed ID: 21393506
[TBL] [Abstract][Full Text] [Related]
2. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
[TBL] [Abstract][Full Text] [Related]
3. Testing the cancer stem cell hypothesis in melanoma: the clinics will tell.
Shakhova O; Sommer L
Cancer Lett; 2013 Sep; 338(1):74-81. PubMed ID: 23073475
[TBL] [Abstract][Full Text] [Related]
4. CD271 is an imperfect marker for melanoma initiating cells.
Cheli Y; Bonnazi VF; Jacquel A; Allegra M; De Donatis GM; Bahadoran P; Bertolotto C; Ballotti R
Oncotarget; 2014 Jul; 5(14):5272-83. PubMed ID: 25105565
[TBL] [Abstract][Full Text] [Related]
5. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
Redmer T; Welte Y; Behrens D; Fichtner I; Przybilla D; Wruck W; Yaspo ML; Lehrach H; Schäfer R; Regenbrecht CR
PLoS One; 2014; 9(5):e92596. PubMed ID: 24799129
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
8. CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in vivo reflectance confocal microscopy.
Beretti F; Manni P; Longo C; Argenziano G; Farnetani F; Cesinaro AM; Witkowski AM; De Pol A; Pellacani G
Br J Dermatol; 2015 Mar; 172(3):662-8. PubMed ID: 25066225
[TBL] [Abstract][Full Text] [Related]
9. CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens.
Furuta J; Inozume T; Harada K; Shimada S
J Invest Dermatol; 2014 May; 134(5):1369-1377. PubMed ID: 24226422
[TBL] [Abstract][Full Text] [Related]
10. Expression of Multidrug Resistance Transporter ABCB5 in a Murine Model of Human Conjunctival Melanoma.
de Waard NE; Kolovou PE; McGuire SP; Cao J; Frank NY; Frank MH; Jager MJ; Ksander BR
Ocul Oncol Pathol; 2015 Apr; 1(3):182-189. PubMed ID: 25960995
[TBL] [Abstract][Full Text] [Related]
11. Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment.
Gray ES; Reid AL; Bowyer S; Calapre L; Siew K; Pearce R; Cowell L; Frank MH; Millward M; Ziman M
J Invest Dermatol; 2015 Aug; 135(8):2040-2048. PubMed ID: 25830652
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain.
Guo R; Fierro-Fine A; Goddard L; Russell M; Chen J; Liu CZ; Fung KM; Hassell LA
Int J Clin Exp Pathol; 2014; 7(12):8947-51. PubMed ID: 25674270
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
[TBL] [Abstract][Full Text] [Related]
14. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.
Graf SA; Busch C; Bosserhoff AK; Besch R; Berking C
J Invest Dermatol; 2014 Aug; 134(8):2212-2220. PubMed ID: 24608986
[TBL] [Abstract][Full Text] [Related]
15. Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.
Tomellini E; Lagadec C; Polakowska R; Le Bourhis X
Cell Mol Life Sci; 2014 Jul; 71(13):2467-81. PubMed ID: 24481864
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.
Al Hmada Y; Brodell RT; Kharouf N; Flanagan TW; Alamodi AA; Hassan SY; Shalaby H; Hassan SL; Haikel Y; Megahed M; Santourlidis S; Hassan M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275910
[TBL] [Abstract][Full Text] [Related]
17. Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer.
Davies GCG; Dedi N; Jones PS; Kevorkian L; McMillan D; Ottone C; Schulze MED; Scott-Tucker A; Tewari R; West S; Wright M; Rowley TF
MAbs; 2023; 15(1):2289681. PubMed ID: 38084840
[TBL] [Abstract][Full Text] [Related]
18. Reactive Oxygen Species Regulation of Chemoresistance and Metastatic Capacity of Melanoma: Role of the Cancer Stem Cell Marker CD271.
Beretti F; Gatti M; Zavatti M; Bassoli S; Pellacani G; Maraldi T
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189846
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas.
Monteiro JM; Reis Ramos JI; Teixeira E Sousa I; Bighetti-Trevisan RL; Ribas Filho JM; Isolan GR
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982406
[TBL] [Abstract][Full Text] [Related]
20. Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma.
Lehmann J; Caduff N; Krzywińska E; Stierli S; Salas-Bastos A; Loos B; Levesque MP; Dummer R; Stockmann C; Münz C; Diener J; Sommer L
Sci Adv; 2023 Jan; 9(2):eadc8825. PubMed ID: 36638181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
